Exp Clin Endocrinol Diabetes 2010; 118(2): 127-132
DOI: 10.1055/s-0029-1215589
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Selective Deficiency of Gsα and the Possible Role of Alternative Gene Products of GNAS in Albright Hereditary Osteodystrophy and Pseudohypoparathyroidism Type Ia

S. Thiele 1 , R. Werner 1 , W. Ahrens 1 , A. Hübner 2 , K. G. Hinkel 3 , W. Höppner 2 , B. Igl 4 , O. Hiort 1
  • 1Departments of Pediatrics, University of Lübeck, Lübeck, Germany
  • 2Departments of Pediatrics, University of Dresden, Dresden, Germany
  • 3Bioglobe Hamburg, Hamburg, Germany
  • 4Institute of Medical Biometry and Statistics, University of Lübeck, Lübeck, Germany
Further Information

Publication History

received 03.11.2008 first decision 09.02.2009

accepted 11.03.2009

Publication Date:
05 August 2009 (online)

Abstract

Objective: Albright hereditary osteodystrophy (AHO) and Pseudohypoparathyroidism type Ia (PHPIa) are caused by an inherited deficiency of Gsα, encoded by the GNAS gene. Apart from an exclusive first exon, Gsα shares part of the transcribed regions with NESP55, Exon A/B and XLαs, whose gene products utilize alternative promoter regions of this complex gene locus. However, it is not known, whether the deficiency of all gene products contributes to the AHO and PHPIa phenotype or if they are even causative for some specific symptoms. In these cases, mutations affecting selectively GNAS exon 1, coding only for Gsα, would lead to a different phenotype than mutations affecting the common exons 2–13.

Methods: Clinical and molecular genetic analysis of a patient with features of AHO and review of exclusive exon 1 mutations of GNAS.

Results: We detected a novel heterozygous 1 bp deletion of a guanine in codon 31 in exon 1 of the GNAS gene leading to a frame shift and premature termination of Gsα. The female patient demonstrated a fully expressed AHO and PHPIa phenotype and a decreased Gsα protein activity of 62% compared to the wild type. Mutations in exon 1 are almost exclusively disruptive and lead to an AHO phenotype that does not show obvious differences from those provoked by missense or nonsense mutations in exon 2–13.

Conclusion: Disruptive mutations in exon 1 indicate that exclusive deficiency of Gsα is sufficient for the expression of an AHO phenotype, which cannot be compensated by alternative products of GNAS.

References

  • 1 Adegbite NS, Xu M, Kaplan FS. et al . Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotropic ossification.  Am J Med Genet. 2008;  146A 1788-1796
  • 2 Ahrens W, Hiort O, Staedt P. et al . Analysis of the GNAS gene in Albright's hereditary osteodystrophy.  J Clin Endocrinol Metab. 2001;  86 4630-4634
  • 3 Aldred MA, Trembath RC. Activating and inactivating mutations in the human GNAS1 gene.  Hum Mutat. 2000;  16 183-189
  • 4 Bastepe M, Gunes Y, Perez-Villamil B. et al . Receptor mediated adenylyl cyclase activation through XLalpha(s), the extra-large variant of the stimulatory G protein alpha-subunit.  Mol Endocrinol. 2002;  16 1912-1919
  • 5 Bastepe M, Juppner H. GNAS locus and pseudohypoparathyroidism.  Horm Res. 2005;  63 65-74
  • 6 Cabrera-Vera TM, Vanhauwe J, Thomas TO. et al . Insights into G protein structure, function, and regulation.  Endocr Rev. 2003;  24 765-781
  • 7 Chen M, Gavrilova O, Liu J. et al . Alternative Gnas gene products have opposite effects on glucose and lipid metabolism.  Proc Natl Acad Sci USA. 2005;  102 7386-7391
  • 8 De Sanctis L, Romagnolo D, Olivero M. et al . Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism.  Pediatr Res. 2003;  53 749-755
  • 9 Eddy MC, Jan De Beur SM, Yandow SM. et al . Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification.  J Bone Miner Res. 2000;  15 2074-2083
  • 10 Fischer JA, Egert F, Werder E. et al . An inherited mutation associated with functional deficiency of the alpha-subunit of the guanine nucleotide-binding protein Gs in pseudo- and pseudopseudohypoparathyroidism.  J Clin Endocrinol Metab. 1998;  83 935-938
  • 11 Germain-Lee EL, Groman J, Crane JL. et al . Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance.  J Clin Endocrinol Metab. 2003;  88 4059-4069
  • 12 Germain-Lee EL, Schwindinger W, Crane JL. et al . A mouse model of Albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the GNAS gene.  Endocrinology. 2005;  146 4697-4709
  • 13 Germain-Lee EL. Short stature, obesity, and growth hormone deficiency in pseudohypoparathyroidism type 1a.  Pediatr Endocrinol Rev. 2006;  3 ((Suppl 2)) 318-327
  • 14 Hayward BE, Bonthron DT. An imprinted antisense transcript at the human GNAS1 locus.  Hum Mol Genet. 2000;  9 835-841
  • 15 Hayward BE, Kamiya M, Strain L. et al . The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins.  Proc Natl Acad Sci USA. 1998;  95 10038-10043
  • 16 Ischia R, Lovisetti-Scamihorn P, Hogue-Angeletti R. et al . Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity.  J Biol Chem. 1997;  272 11657-11662
  • 17 Ishikawa Y, Bianchi C, Nadal-Ginard B. et al . Alternative promoter and 5′ exon generate a novel Gs alpha mRNA.  Journal of Biological Chemistry. 1990;  265 8458-8462
  • 18 Kehlenbach RH, Matthey J, Huttner WB. XL alpha s is a new type of G protein.  Nature. 1994;  372 804-809
  • 19 Klemke M, Pasolli A, Kehlenbach RH. et al . Characterization of the extra-large G protein α-subunit XLαs. Signal transduction properties.  J Biol Chem. 2000;  275 33633-33640
  • 20 Kozasa T, Itoh H, Tsukamoto T. et al . Isolation and characterization of the human Gs alpha gene.  Proc Natl Acad Sci USA. 1988;  85 2081-2085
  • 21 Lim SH, Poh LK, Cowell CT. et al . Mutational analysis of the GNAS1 exons encoding the stimulatory G protein in five patients with pseudohypoparathyroidism type 1a.  J Pediatr Endocrinol Metab. 2002;  15 259-268
  • 22 Linglart A, Mahon MJ, Kerachian MA. et al . Coding GNAS mutations leading to hormone resistance impair in vitro agonist- and cholera toxin-induced cAMP formation mediated by human XLαs.  Endocrinology. 2006;  147 2253-2262
  • 23 Liu J, Litman D, Rosenberg MJ. et al . A GNAS1 imprinting defect in pseudohypoparathyroidism type IB.  J Clin Invest. 2000;  106 1167-1174
  • 24 Long DN, MacGuire S, Levine MA. et al . Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity.  J Clin Endocrinol Metab. 2007;  92 1073-1079
  • 25 Mantovani G, Romoli R, Weber G. et al . Mutational analysis of GNAS1 in patients with pseudohypoparathyroidism: identification of two novel mutations.  J Clin Endocrinol Metab. 2000;  85 4243-4248
  • 26 Passoli H, Klemke M, Kehlenbach RH. et al . Characterization of the extra-large G protein alpha-subunit XLalphas. I. Tissue distribution and subcellular localization.  J Biol Chem. 2000;  275 33622-33632
  • 27 Patten JL, Johns DR, Valle D. et al . Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy.  N Engl J Med. 1990;  322 1412-1419
  • 28 Plagge A, Gordon E, Dean W. et al . The imprinted signalling protein XL alpha s is required for postnatal adaptation to feeding.  Nat Genet. 2004;  36 818-826
  • 29 Plagge A, Isles AR, Gordon E. et al . Imprinted Nesp55 influences behavioral reactivity to novel environments.  Mol Cell Biol. 2005;  25 3019-3026
  • 30 Rickard JS, Wilson LC. Analysis of GNAS1 and overlapping transcripts identifies the parental origin of mutations in patients with sporadic Albright hereditary Osteodystrophy and reveals a model system in which to observe the effects of splicing mutations on translated and untranslated messenger RNA.  Am J Hum Genet. 2003;  72 961-974
  • 31 Shore EM, Ahn J, Jan de Beur S. et al . Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.  N Engl J Med. 2002;  346 99-106
  • 32 Weinstein LS, Chen M, Liu J. Gs(alpha) mutations and imprinting defects in human disease.  Ann N Y Acad Sci. 2002;  968 173-197
  • 33 Wettschureck N, Offermanns S. Mammalian G proteins and their cell type specific functions.  Physiol Rev. 2005;  85 1159-1204
  • 34 Williamson CM, Turner MD, Ball ST. et al . Identification of an imprinting control region affecting the expression of all transcripts in the Gnas cluster.  Nat Genet. 2006;  38 350-355
  • 35 Xie T, Chen M, Gavrilova O. et al . Severe obesity and insulin resistance due to deletion of the maternal Gsα allele is reversed by paternal deletion of the Gsα imprint control region.  Endocrinology. 2008;  149 2443-2550
  • 36 Xie T, Plagge A, Gavrilova O. et al . The alternative stimulatory G protein alpha-subunit XLalpha s is a critical regulator of energy and glucose metabolism and sympathetic nerve activity in adult mice.  J Biol Chem. 2006;  281 18989-18999
  • 37 Yu S, Gavrilova O, Chen H. Paternal versus maternal transmission of a stimulatory G-protein alpha subunit knockout produces opposite effects on energy metabolism.  J Clin Invest. 2000;  105 615-623
  • 38 Yu S, Yu D, Lee E. et al . Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene.  Proc Natl Acad Sci USA. 1998;  95 8715-8720

Correspondence

O. HiortMD 

Division of Pediatric Endocrinology and Diabetes

Department of Pediatrics and Adolescent Medicine

University of Luebeck

Ratzeburger Allee 160

23538 Lübeck

Germany

Phone: +49/451/500 21 91

Fax: +49/451/500 68 67

Email: hiort@paedia.ukl.mu-luebeck.de

    >